XML 16 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 27, 2020
Sep. 29, 2019
Sep. 27, 2020
Sep. 29, 2019
Revenue:        
Total revenue $ 794 $ 907 $ 2,286 $ 2,591
Cost of revenue:        
Amortization of acquired intangible assets 7 9 21 28
Total cost of revenue 268 259 713 786
Gross profit 526 648 1,573 1,805
Operating expense:        
Research and development 172 151 483 486
Selling, general and administrative 192 189 643 602
Total operating expense 364 340 1,126 1,088
Income from operations 162 308 447 717
Other income (expense):        
Interest income 5 16 26 59
Interest expense (11) (11) (33) (41)
Other income (expense), net 59 (43) 117 114
Total other income (expense), net 53 (38) 110 132
Income before income taxes 215 270 557 849
Provision for income taxes 36 36 158 98
Consolidated net income 179 234 399 751
Add: Net loss attributable to noncontrolling interests 0   0 12
Net income attributable to Illumina stockholders $ 179 $ 234 $ 399 $ 763
Earnings per share attributable to Illumina stockholders:        
Basic (in dollars per share) $ 1.22 $ 1.59 $ 2.72 $ 5.19
Diluted (in dollars per share) $ 1.21 $ 1.58 $ 2.70 $ 5.13
Shares used in computing earnings per share:        
Basic (in shares) 146 147 147 147
Diluted (in shares) 148 148 148 149
Product revenue        
Revenue:        
Total revenue $ 676 $ 746 $ 1,904 $ 2,117
Cost of revenue:        
Cost of revenue 209 195 535 573
Service and other revenue        
Revenue:        
Total revenue 118 161 382 474
Cost of revenue:        
Cost of revenue $ 52 $ 55 $ 157 $ 185